MeSH term
Frequency | Condition_Probility | Female | 13 | 0.0 |
Humans | 33 | 0.0 |
Pregnancy | 4 | 0.0 |
Blotting, Western | 3 | 0.0 |
Cell Adhesion | 3 | 0.0 |
Cytoskeletal Proteins/metabolism | 3 | 1.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Gene Expression | 5 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Neoplasm Invasiveness | 3 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
*Trans-Activators | 5 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Transfection | 4 | 0.0 |
Tumor Cells, Cultured | 8 | 0.0 |
Base Sequence | 4 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
*Zebrafish Proteins | 9 | 4.0 |
Comparative Study | 4 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Male | 3 | 0.0 |
Middle Aged | 2 | 0.0 |
Cyclin D1/metabolism | 2 | 1.0 |
Disease Progression | 3 | 0.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 7 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
RNA, Neoplasm/genetics | 3 | 0.0 |
Prognosis | 2 | 0.0 |
Signal Transduction | 4 | 0.0 |
Animals | 17 | 0.0 |
Cell Differentiation | 4 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
DNA-Binding Proteins/biosynthesis | 2 | 2.0 |
Homeodomain Proteins/biosynthesis | 4 | 25.0 |
In Situ Hybridization | 5 | 0.0 |
Mice | 8 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Cell Line | 6 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Proteins/genetics/*metabolism | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
Proteins/metabolism | 3 | 0.0 |
Receptors, Neurotransmitter/*metabolism | 2 | 7.0 |
Amino Acid Sequence | 5 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Proteins/*genetics | 3 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
*Gene Expression | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 11 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
Mesoderm/cytology | 2 | 5.0 |
*Signal Transduction | 2 | 0.0 |
Ligands | 3 | 0.0 |
Tissue Distribution | 2 | 0.0 |
*Chromosomes, Human, Pair 3 | 2 | 0.0 |
Breast/*metabolism | 2 | 3.0 |
Cell Line, Transformed | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Embryonic and Fetal Development/*genetics | 2 | 2.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Tail/*embryology | 2 | 100.0 |
Growth Substances/biosynthesis | 2 | 10.0 |
Protein Biosynthesis | 2 | 0.0 |
Proto-Oncogene Proteins/biosynthesis | 2 | 1.0 |
Down-Regulation | 3 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Tumor Markers, Biological/*metabolism | 2 | 0.0 |
